Nu-Med Plus (NUMD) Other Non Operating Income (2015 - 2021)

Nu-Med Plus (NUMD) reported Other Non Operating Income of $9384.0 for Q2 2021, up 100.14% sequentially from -$6.7 million in Q4 2017.

Nu-Med Plus (NUMD) Other Non Operating Income (2015 - 2021) Analysis & Trends

Nu-Med Plus (NUMD) has 4 years of Other Non Operating Income data on file, last reported at $9384.0 in Q2 2021.

For the quarter ending Q2 2021, Other Non Operating Income changed N/A year-over-year to $9384.0; the trailing twelve-month figure through Dec 2021 stood at $9384.0 (changed N/A YoY), and the FY2022 full-year result was $50000.0, up 432.82% from the prior year.
Other Non Operating Income rose to $9384.0 in Q2 2021, from -$6.7 million in the prior quarter.
In the past five years, Other Non Operating Income ranged from a high of $9384.0 in Q2 2021 to a low of -$6.7 million in Q1 2017.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	201.40 Bn	194.75 Bn	6.27 Bn
2	Stryker	122.29 Bn	119.41 Bn	3.81 Bn
3	Medtronic	105.01 Bn	96.40 Bn	6.41 Bn
4	Boston Scientific	64.81 Bn	63.59 Bn	3.61 Bn
5	Edwards Lifesciences	55.28 Bn	51.60 Bn	1.29 Bn
6	Dexcom	29.06 Bn	27.94 Bn	750.30 Mn
7	Koninklijke Philips	29.02 Bn	25.93 Bn	2.07 Bn
8	GE HealthCare Technologies	28.27 Bn	26.20 Bn	1.98 Bn
9	Smith & Nephew	25.80 Bn	25.22 Bn	-
10	Nu-Med Plus	1.67 Mn	1.67 Mn	-

Download Data